Free Trial

Life360 (LIF) Competitors

Life360 logo
$41.40 +1.15 (+2.86%)
Closing price 04:00 PM Eastern
Extended Trading
$40.80 -0.60 (-1.45%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LIF vs. RTO, ALLE, FTAI, CART, ULS, MEDP, STN, BILI, HQY, and WPP

Should you be buying Life360 stock or one of its competitors? The main competitors of Life360 include Rentokil Initial (RTO), Allegion (ALLE), FTAI Aviation (FTAI), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Bilibili (BILI), HealthEquity (HQY), and WPP (WPP). These companies are all part of the "business services" industry.

Life360 vs.

Rentokil Initial (NYSE:RTO) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.

Rentokil Initial has a net margin of 0.00% compared to Life360's net margin of -4.72%. Rentokil Initial's return on equity of 0.00% beat Life360's return on equity.

Company Net Margins Return on Equity Return on Assets
Rentokil InitialN/A N/A N/A
Life360 -4.72%-4.03%-3.16%

Rentokil Initial has higher revenue and earnings than Life360.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rentokil Initial$5.44B2.12$473.93M$1.5115.09
Life360$371.48M8.42-$28.17MN/AN/A

Life360 received 10 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 83.33% of users gave Life360 an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
Rentokil InitialOutperform Votes
5
35.71%
Underperform Votes
9
64.29%
Life360Outperform Votes
15
83.33%
Underperform Votes
3
16.67%

Life360 has a consensus target price of $47.63, suggesting a potential upside of 15.04%. Given Life360's stronger consensus rating and higher probable upside, analysts plainly believe Life360 is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rentokil Initial
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
Life360
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

In the previous week, Life360 had 5 more articles in the media than Rentokil Initial. MarketBeat recorded 10 mentions for Life360 and 5 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.72 beat Life360's score of 1.23 indicating that Rentokil Initial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rentokil Initial
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Life360
5 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 20.0% of Life360 shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Life360 beats Rentokil Initial on 8 of the 15 factors compared between the two stocks.

Remove Ads
Get Life360 News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIF vs. The Competition

MetricLife360Data processing & preparation IndustryIndustrials SectorNASDAQ Exchange
Market Cap$3.13B$3.97B$7.08B$8.30B
Dividend YieldN/A3.39%3.54%4.02%
P/E RatioN/A67.8721.0519.25
Price / Sales8.42633.0574.1094.10
Price / CashN/A33.7426.8334.64
Price / BookN/A6.093.744.46
Net Income-$28.17M$42.75M$793.45M$247.07M
7 Day Performance3.34%1.39%0.06%3.05%
1 Month Performance-1.66%-3.84%0.14%-2.85%
1 Year PerformanceN/A12.91%28.79%4.63%

Life360 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIF
Life360
2.4374 of 5 stars
$41.40
+2.9%
$47.63
+15.0%
N/A$3.13B$371.48M0.00600Positive News
High Trading Volume
RTO
Rentokil Initial
2.2845 of 5 stars
$22.18
+1.4%
N/A-25.2%$11.20B$5.44B14.6962,900Positive News
ALLE
Allegion
4.602 of 5 stars
$127.42
+0.6%
$138.33
+8.6%
-2.6%$10.99B$3.77B18.6811,000Positive News
FTAI
FTAI Aviation
3.9122 of 5 stars
$106.98
+2.6%
$173.67
+62.3%
+75.8%$10.97B$1.73B-1,069.6940
CART
Maplebear
3.9781 of 5 stars
$40.64
+5.4%
$50.52
+24.3%
+9.0%$10.76B$3.38B27.283,380Positive News
ULS
UL Solutions
1.7202 of 5 stars
$52.34
+0.2%
$51.45
-1.7%
N/A$10.48B$2.87B32.3115,233News Coverage
Positive News
MEDP
Medpace
4.1484 of 5 stars
$326.34
+0.4%
$381.44
+16.9%
-19.1%$9.94B$2.11B25.845,900Analyst Upgrade
News Coverage
Positive News
STN
Stantec
2.2705 of 5 stars
$83.63
+1.4%
N/A-2.9%$9.54B$7.50B38.0128,000Positive News
BILI
Bilibili
1.9386 of 5 stars
$22.28
+3.9%
$21.11
-5.3%
+81.8%$9.23B$26.83B-49.5112,300Positive News
Gap Down
HQY
HealthEquity
3.2484 of 5 stars
$100.72
+3.4%
$112.92
+12.1%
+13.4%$8.73B$1.15B92.403,150Analyst Forecast
News Coverage
WPP
WPP
2.4345 of 5 stars
$40.27
+1.0%
N/A-15.1%$8.69B$14.74B6.75114,732
Remove Ads

Related Companies and Tools


This page (NASDAQ:LIF) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners